Published by Coherent Market Insights
Posted on September 22, 2021
3 min readLast updated: February 3, 2026
The ingestible smart pills market is set to grow at a 5.7% CAGR from 2021-2027, driven by increased adoption in healthcare and innovations in medical technology.
Ingestible Smart Pills Market Report 2021-2027 includes a comprehensive analysis of the present Market. The report starts with the basic Ingestible Smart Pills industry overview and then goes into each and every detail.
Ingestible Smart Pills Market Report contains in depth information major manufacturers, opportunities, challenges, and industry trends and their impact on the market forecast. Ingestible Smart Pills also provides data about the company and its operations. This report also provides information on the Pricing Strategy, Brand Strategy, Target Client, Distributors/Traders List offered by the company.
Click Here To Get Sample Copy @ https://www.coherentmarketinsights.com/insight/request-sample/4091
Currently known by several different names including ingestible tech, smart pills and electronic medicine, ingestible technology specifically refers to medical, electronic devices which are ingested by users to achieve or facilitate a wide range of medical care or diagnosis purposes. Some of the most common uses for this technology include promoting treatment for obesity, cardiac problems, pain management, brain function, and even stress management.
Key Market Drivers:
Increasing adoption of smart pills is expected to propel growth of the global ingestible smart pills market over the forecast period. For instance, in January 2020, New University of Colorado adopted etectRx, Inc.’s ID-Cap System in a clinical study of 180 patients to create a reliable record of adherence for over 20,000 doses of HIV medication.
Moreover, increasing prevalence of gastrointestinal diseases is expected to propel growth of the global ingestible smart pills market over the forecast period. For instance, according to the study, ‘A study of prevalence and determinants of irritable bowel syndrome in an urban slum community in Mumbai’, published in November 2018, the prevalence of irritable bowel syndrome was 12.27%, of which 56% were males and 44% were females.
Covid-19 Impact Analysis
The current coronavirus disease 2019 pandemic is placing a huge strain on health systems worldwide. As of August 17, 2021, the United Kingdom reported 6,295,613 coronavirus cases. Ingestible smart pills can help manage chronic conditions and promote medication adherence during the pandemic, which in turn is expected to ease the burden on already strained health systems. Such scenario is expected to offer lucrative growth opportunities for players in the ingestible smart pills market.
Key Takeaways
The ingestible smart pills market is expected to exhibit a CAGR of XX % over the forecast period, owing to increasing funding in smart pills. For instance, in March 2021, Vibrant, a medical technology company, raised US$ 7.5 million for a drug-free mechanical pill to treat constipation.
Among regions, North America is expected to witness significant growth in the ingestible smart pills market, owing to R&D in smart pills. For instance, in June 2019, etectRx Inc. announced that the United States Patent and Trademark Office has issued U.S. Patent 10,292,642 for an “Electronic Medication Compliance Monitoring System and Associated Methods.”
Top Key Players Include In Ingestible Smart Pills Market: BodyCap Medical, Given Imaging Ltd., Olympus Corporation, Proteus Digital Health, Inc., CapsoVision, Inc., Chongqing Jinshan Science and Component (Group) Co., Ltd., Medimetrics, IntroMedic Co., Ltd., Check-Cap Ltd., Boston Scientific Corporation, HQ Inc., Smart Pill Inc., Medtronic plc, Philips Healthcare, etectRx, Inc., Novartis, Siemens Healthcare, Pentax Medical Company (HOYA Corporation), GE Healthcare, and Stryker Corporation.
Get This premium report with Instant US$ 2000 discount @ https://www.coherentmarketinsights.com/promo/buynow/4091
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Phone: US +12067016702 / UK +4402081334027
Email: sales@coherentmarketinsights.com
The post Ingestible Smart Pills Market, projected to grow at CAGR of 5.7% during the forecast period 2021-2027 | In-Depth Research on Market Dynamics, Applications & Emerging Growth Factors appeared first on Gatorledger.
The article discusses the growth and dynamics of the ingestible smart pills market from 2021 to 2027.
Ingestible smart pills are electronic devices ingested for medical diagnosis and treatment purposes.
Increased adoption of smart pills and healthcare innovations are key drivers of market growth.
Explore more articles in the Research Reports category
